Recent

% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. (SNTA) Message Board

  • baboooooooz baboooooooz May 7, 2013 12:35 PM Flag

    BMO capital DOWNGRADES GUANO

    BMO Capital downgraded Synta Pharma. (NASDAQ: SNTA) from Outperform to Market Perform with a price target of $9.00 (from $18.00) following the resignation of the company's R&D President Sumant Ramachandra.

    For an analyst ratings summary and ratings history on Synta Pharma. click here. For more ratings news on Synta Pharma. click here.

    Shares of Synta Pharma. closed at $9.37 yesterday, with a 52 week range of $3.57-$11.88.

 
SNTA
2.30-0.07(-2.95%)Mar 26 4:00 PMEDT